CDXC May 2024 5.000 put
| Previous close | 1.2400 |
| Open | 1.2400 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 5.00 |
| Expiry date | 2024-05-17 |
| Day's range | 1.2400 - 1.2400 |
| Contract range | N/A |
| Volume | |
| Open interest | 8 |
Simply Wall St.An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 43% Undervalued
Key Insights The projected fair value for ChromaDex is US$6.63 based on 2 Stage Free Cash Flow to Equity ChromaDex's...
Business WireChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
LOS ANGELES, April 30, 2024--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announces an ingredient partnership with Solgar®, a Nestlé Health Science brand. Solgar’s inaugural NAD+ supplement, Solgar Cellular Nutrition Cellular Energy, features ChromaDex’s patented nicotinamide riboside (NR) ingredient, NIAGEN® to support NAD+ levels for cellular health. This product marks a significant milestone in the health and welln
Business WireChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
LOS ANGELES, April 25, 2024--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announces that its flagship consumer supplement, Tru Niagen®, is now available at The Vitamin Shoppe retail locations nationwide and online at www.vitaminshoppe.com. This retail expansion adds Tru Niagen to the shelves of 700 locations of The Vitamin Shoppe and Super Supplements, enhancing consumer access to the number one healthy-aging NAD+ sup
